Skip to main content

JHOP - October 2025 Vol 15, No 5

Case Reports
Original Research
Case Reports
Online First
Case Reports, Adverse Events, Immunotherapy, Infusion Issues, Monoclonal Antibodies
Management of Severe Hypersensitivity Reaction and Serum Sickness in a Case of Aplastic Anemia: Case Report Using Tocilizumab
David C. Sabatino, PharmD, BCOP; Alina Varabyeva, PharmD, BCOP; Joseph Jurcic, MD
Read More
Online First
Case Reports, Breast Cancer, Chemotherapy
Highly Effective Treatment for Bone-Only Signet Ring Cell Breast Cancer With Ribociclib, Fulvestrant, and Denosumab: A Case Study
Marjorie Ford Nenadich, PharmD, BS; Michelle Faith Nenadich, BSN; Basel Shoua, MD
Read More
Original Research
Original Research, Anticoagulants, Multiple Myeloma, Thromboembolism
Safety and Efficacy of Direct Oral Anticoagulants as Thromboprophylaxis in Patients With Multiple Myeloma Receiving a Lenalidomide-Based Induction Regimen
Christopher Wang, PharmD, BCOP; Chelsea Luo, PharmD, BCOP; Brian Primeaux, PharmD, BCOP
Read More
Original Research, Adverse Events, PARP Inhibitors
Prospective Pharmacist-Led Monitoring of Patients Initiating PARP Inhibitor Therapy in the United States
Brooke D. Looney, PharmD, CSP; Stephanie G. White, PharmD, CSP; Ryan Moore, MS; Autumn D. Zuckerman, PharmD, BCPS, CSP; Leena Choi, PhD, et al.
Read More
Online First
Original Research, Thromboembolism, Gastrointestinal Cancers
Evaluation of Bleeding Risk With Apixaban Versus Rivaroxaban in Patients With Gastrointestinal Cancer
Parker Gundersen, PharmD, MBA, BCOP; Alexa Basilio, PharmD, BCOP; Amber Draper, PharmD, BCOP; Marley Watson, PharmD, BCOP; Emily Tiao, PharmD, BCOP, et al.
Read More